GRIT BIOTECHNOLOGY. INC
- Biotech or pharma, therapeutic R&D
Grit Biotechnology ("Grit Bio") is a clinical stage privately TIL-focused biotech backed by leading healthcare investors. Grit Bio is a clinical-stage biotech pioneering advanced immunotherapies for unmet clinical needs in cancers and autoimmune diseases. The company has established a robust pipeline of tumour-infiltrating lymphocyte (TIL) cell therapies, neoantigen cancer vaccine, and off-the-shelf cell therapies. Besides the pipeline products. Our conference focus is to find global partners for our late stage assets (TIL portfolios) and also our assets at early stage (CAR-NKT, neoantigen cancer vaccine and in vivo CAR). Currently, we have already generated initial clinical data and safety data from our CAR-NKT product in autoimmune patients. We are expected to initiate IITs and following IND-enabling process for in vivo CAR and neoantigen cancer vaccine very soon. Happy to discuss if there's any kind of collaboration.
** Sorry we don't accept meetings from vendors*
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}